Drug recall · October 31, 2018
Lidocaine 1% + Epinephrine 1:100 recall
Why: Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450
- Lots / codes
Lot# 04042018:58, Exp 10/17/18
- Quantity
- 395 vials
- Company
- RXQ Compounding LLC, Athens, OH
- Distribution
- U.S.A. nationwide
- Initiated
- September 25, 2018 · Voluntary: Firm initiated
- Classified
- November 1, 2018
- Reported
- October 31, 2018
- Ended
- October 18, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.